共 415 条
[41]
Ste-Marie PA(2017)Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials Pain Physician 20 E755-998
[42]
Shir Y(2020)Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials Epilepsia 61 1082-190
[43]
Dowell D(2020)Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis Support Care Cancer 28 2095-52
[44]
Haegerich TM(2021)Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials Pain Med 22 861-153
[45]
Chou R(2019)Benefits and harms of medical cannabis: a scoping review of systematic reviews Syst Rev 8 320-4576
[46]
Genova A(2007)Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis Biochem Biophys Res Commun 359 884-15
[47]
Dix O(2014)Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis Rheumatology (Oxford) 53 802-109
[48]
Thakur M(2020)Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts Cell Death Dis 11 714-948
[49]
Sangha PS(2008)Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis Arthritis Res Ther 10 R43-2012
[50]
Shraim MA(2016)The synthetic cannabinoid WIN55,212–2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets J Inflamm (Lond) 13 15-51